|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
174,790 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$6,584,566 |
|
|
Indirect Value
|
$17,850,076 |
|
|
Total
Shares |
592,616 |
|
|
Total
Value |
$24,434,642 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
127.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-02-27 |
122,854 |
2024-02-27 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
2024-05-31 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive OfficerOfficer |
|
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
374,544 |
|
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,250 |
|
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
AS |
$80.01 |
$1,600 |
D/D |
(20) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
OE |
$0.30 |
$6 |
D/D |
20 |
20 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
42 |
282 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-03-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
190 |
94,511 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2023-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
240 |
240 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-09-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
271,772 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-13 |
4 |
AS |
$120.31 |
$82,292 |
I/I |
(684) |
106,401 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2022-02-22 |
4 |
D |
$29.08 |
$22,043 |
D/D |
(758) |
116,294 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2015-02-11 |
4 |
AS |
$120.14 |
$94,550 |
I/I |
(787) |
107,085 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(821) |
112,591 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2020-02-24 |
4 |
D |
$48.66 |
$42,821 |
D/D |
(880) |
105,053 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2016-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,176 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,176 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-11-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
270,772 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
5,176 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-06-06 |
4 |
OE |
$0.30 |
$333 |
D/D |
1,100 |
1,100 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-06-06 |
4 |
AS |
$50.02 |
$55,022 |
D/D |
(1,100) |
0 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
Director |
|
2014-12-19 |
4 |
B |
$85.00 |
$99,960 |
D/D |
1,176 |
1,176 |
2.39 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
117,879 |
0 |
- |
|
BLUE |
Bluebird Bio, Inc. |
|
|
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,656 |
6,832 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
114,277 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-06-07 |
4 |
OE |
$0.30 |
$575 |
D/D |
1,900 |
1,900 |
0 |
- |
|
154 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|